{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/d348aacb-00cd-4b2d-9b3b-ee9d99cdb735/69441c04f13209aaa3d3f656?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The downsides of weight-loss drugs (Revisited)","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba18761a8cbe923a3cf195/1766071358857-3b16dc4d-3d5d-4947-9311-fdf4ae103ae7.jpeg?height=200","description":"<p>Weight loss drugs can be transformative for people who have struggled with obesity. But with a spike in hospital admissions experiencing adverse reactions to the drugs, should we be doing more to regulate this growing market?&nbsp;</p><p>Writer: James Tapper</p><p>Producer: Ada Barumé</p><p>Host: Tomini Babs&nbsp;</p><p>Executive producer: Rebecca Moore</p><p><br></p>","author_name":"The Observer"}